1. SYNTHESIS OF FLUORINATED HYDROXYCINNAMOYL DERIVATIVES OF ANTI-INFLUENZA DRUGS AND THEIR BIOLOGICAL ACTIVITY.
- Author
-
Stoykova, Boyka, Chochkova, Maya, Ivanova, Galya, Mukova, Luchia, Nikolova, Nadya, Nikolaeva-Glomb, Lubomira, Vojtíšek, Pavel, Milkova, Tsenka, Štícha, Martin, and Havlíček, David
- Subjects
- *
H5N1 Influenza , *VIRUS diseases , *VACCINES , *AMANTADINE , *RIMANTADINE , *NEURAMINIDASE - Abstract
The emergence of a novel pandemic influenza A (H1N1) strain in 2009 is an evident mark for the unremitting risk of respiratory viral diseases. Influenza outbreaks and development of desease and could be overcome by use of vaccines and antivirals. Currently, clinically applied influenza antivirals are limited to M2 ion channel blockers (amantadine and rimantadine) and neuraminidase inhibitors (oseltamivir and zanamivir). Development of resistant viral progeny though, is one of the major challenges to antiviral chemotherapy, in general. Resistant viral mutants are described to both classes of anti-influenza antivirals, as well. Therefore, the development of new antiviral agents for influenza treatment is a hot topic and a never ending task. Combining antiviral drugs with antioxidants in severe influenza-associated complications is of great therapeutic significance. Based on the prominent antioxidant activity of hydroxycinnamic acids, herein, we report the biological activity of newly synthesized amides obtained by coupling previously synthesized N-hydroxycinnamoyl amides of fluorinated amino acids and a fragment of oseltamivir. [ABSTRACT FROM AUTHOR]
- Published
- 2015